Back to results
US 2017/0362251 A1Published application
Phosphoinositide 3-kinase inhibitors with a zinc binding moiety
AssigneeCuris, Inc.
InventorsXiong Cai, Haixiao Zhai, Chengjung Lai, Chenggeng Qian
Life of this patent
Estimating the term…
Abstract
The instant application relates to deazapurines, thienopyrimidines and furopyrimidines with zinc-binding moiety based derivatives and their use in the treatment of phosphoinositide 3-kinase related diseases and disorders such as cancer. The instant application further relates to the treatment of histone deacetylase related disorders and diseases related to both histone deacetylase and phosphoinositide 3-kinase.
Claims20
A compound represented by formula (I);
- or a geometric isomer, enantiomer, diastereomer, racemate, pharmaceutically acceptable salt, or prodrug thereof,
- wherein represents a single or double bond;
- q, r and s are independently 0 or 1, wherein at least one of q, r and s is 1;
- t is 0 or 1;
- n is 0, 1, 2, 3 or 4;
- p is 0, 1 or 2;
- X and Y are independently CR1, N(R8), S or O, wherein when one of X and Y is CR1, the other is N(R8), S or O;
- G1 is CR1, S, O, NR10 or NS(O)2R10;
- G2 is substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl or, substituted or unsubstituted heterocyclic;
- G3 is substituted or unsubstituted C1-C8 alkyl, substituted or unsubstituted C2-C8 alkenyl, or, substituted or unsubstituted C2-C8 alkynyl;
- each R8 is independently hydrogen, acyl, aliphatic or substituted aliphatic;
- each R1 and R2 is independently selected from absent, hydrogen, hydroxy, amino, halogen, alkoxy, alkylamino, dialkylamino, CF3, CN, NO2, sulfonyl, acyl, aliphatic, substituted aliphatic, aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocyclic, and substituted heterocyclic;
- Ra is optionally substituted alkyl, optionally substituted aryl or optionally substituted heteroaryl;
- Rb is hydrogen, optionally substituted alkyl, optionally substituted aryl or optionally substituted heteroaryl;
- or Ra and Rb, together with the nitrogen atom to which they are attached, form an optionally substituted heterocyclic group;
- R10 is selected from hydrogen, hydroxy, amino, alkoxy, alkylamino, dialkylamino, sulfonyl, acyl, aliphatic, substituted aliphatic, aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocyclic, and substituted heterocyclic;
- B is a linker;
- and
- C is selected from:
- where W is O or S;
- J is O, NH or NCH3;
- and R31 is hydrogen or lower alkyl;
- where W is O or S;
- Y2 is absent, N, or CH;
- Z is N or CH;
- R32 and R34 are independently hydrogen, hydroxy, aliphatic group, provided that if R32 and R34 are both present, one of R32 or R34 must be hydroxy and if Y2 is absent, R34 must be hydroxy;
- and R33 is hydrogen or aliphatic group;
- where W is O or S;
- Y1 and Z1 are independently N, C or CH;
- and
- where Z, Y2, and W are as previously defined;
- R11 and R12 are independently selected from hydrogen or aliphatic;
- R21, R22 and R23 are independently selected from hydrogen, hydroxy, amino, halogen, alkoxy, alkylamino, dialkylamino, CF3, CN, NO2, sulfonyl, acyl, aliphatic, substituted aliphatic, aryl, substituted aryl, heteroaryl, substituted heteroaryl, heterocyclic, and substituted heterocyclic.
30 more elements
Dependencies are inferred from the claim text.